Wells Fargo
TMDX icon

Wells Fargo’s Transmedics TMDX Stock Holding History

Wells Fargo’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.2M Buy
273,801
+15,251
+6% +$1.99M 0.01% 1307
2025
Q4 		$31.5M Buy
258,550
+33,769
+15% +$4.24M 0.01% 1202
2025
Q3 		$25.2M Buy
224,781
+27,595
+14% +$3.23M ﹤0.01% 1339
2025
Q2 		$26.4M Sell
197,186
-16,084
-8% -$1.77M 0.01% 1220
2025
Q1 		$14.3M Buy
213,270
+43,792
+26% +$3.01M ﹤0.01% 1578
2024
Q4 		$10.6M Buy
169,478
+36,722
+28% +$3.42M ﹤0.01% 1843
2024
Q3 		$20.8M Buy
132,756
+7,275
+6% +$1.12M ﹤0.01% 1270
2024
Q2 		$18.9M Sell
125,481
-51,857
-29% -$6.22M ﹤0.01% 1281
2024
Q1 		$13.1M Sell
177,338
-17,542
-9% -$1.45M ﹤0.01% 1531
2023
Q4 		$15.4M Sell
194,880
-259
-0.1% -$15.6K ﹤0.01% 1362
2023
Q3 		$10.7M Buy
195,139
+11,594
+6% +$835K ﹤0.01% 1521
2023
Q2 		$15.4M Buy
183,545
+160,987
+714% +$12.3M ﹤0.01% 1303
2023
Q1 		$1.71M Buy
22,558
+1,949
+9% +$135K ﹤0.01% 2996
2022
Q4 		$1.27M Sell
20,609
-20,843
-50% -$1.11M ﹤0.01% 3097
2022
Q3 		$1.73M Buy
41,452
+32,746
+376% +$1.42M ﹤0.01% 2847
2022
Q2 		$274K Sell
8,706
-10,525
-55% -$281K ﹤0.01% 4115
2022
Q1 		$518K Sell
19,231
-8,860
-32% -$159K ﹤0.01% 4382
2021
Q4 		$538K Buy
28,091
+16,228
+137% +$407K ﹤0.01% 4604
2021
Q3 		$392K Buy
11,863
+2,455
+26% +$75K ﹤0.01% 4797
2021
Q2 		$313K Sell
9,408
-7,009
-43% -$194K ﹤0.01% 4850
2021
Q1 		$681K Sell
16,417
-30,051
-65% -$925K ﹤0.01% 4508
2020
Q4 		$924K Buy
46,468
+10,544
+29% +$156K ﹤0.01% 4088
2020
Q3 		$495K Sell
35,924
-6,478
-15% -$111K ﹤0.01% 4343
2020
Q2 		$760K Buy
42,402
+21,763
+105% +$340K ﹤0.01% 4035
2020
Q1 		$250K Buy
20,639
+7,246
+54% +$121K ﹤0.01% 4536
2019
Q4 		$254K Buy
13,393
+10,015
+296% +$184K ﹤0.01% 4817
2019
Q3 		$80K Buy
3,378
+3,328
+6,656% +$79.8K ﹤0.01% 5414
2019
Q2 		$1K Buy
+50
New +$1.36K ﹤0.01% 6287

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo's TMDX Position: Q1 2026 in Review

Wells Fargo increased its Transmedics (TMDX) stake by 5.9% in Q1 2026, buying an estimated $1.99M and bringing the position to 273,801 shares worth $27.2M. The position accounts for 0.01% of the portfolio, ranked #1307.

Wells Fargo first reported a position in TMDX in Q2 2019 and has held it in 28 quarters since. The position peaked at $31.5M in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Wells Fargo held 273,801 shares of Transmedics worth $27.2M as of Q1 2026.
  • Wells Fargo bought 15,251 Transmedics shares in Q1 2026, an estimated $1.99M.
  • Transmedics made up 0.01% of Wells Fargo's portfolio in Q1 2026, its #1307 holding.
  • Wells Fargo first reported a position in Transmedics in Q2 2019 and has held it in 28 quarters since.
  • Wells Fargo's Transmedics position peaked at $31.5M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.